Cadila Healthcare informs about company updates

16 Aug 2016 Evaluate

Cadila Healthcare has informed that the Company’s Topical manufacturing facility located at Changodar, Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA following the inspection carried out in March 2016. The receipt of EIR indicates the successful closure of the inspection points (483s) raised. The topical plant is a dedicated facility for manufacturing ointments and does not form a part of the Moraiya formulations manufacturing plant.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

916.80 2.30 (0.25%)
02-Jan-2026 12:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1727.00
Dr. Reddys Lab 1249.60
Cipla 1507.35
Zydus Lifesciences 916.80
Lupin 2108.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×